Become A Featured Company

Why DELIC’s Latest Acquisition is a Complete Game-Changer

Ryan Allway

March 8th, 2021

App, Exclusive, Psychedelics, Top Story

The Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) team has been at the forefront of the cannabis industry for over a decade. After building High Times into the giant it is today, they founded DELIC as an umbrella platform to target the nascent psychedelics industry through a combination of media properties, high-profile events, wellness clinics and more.

Let’s take a look at the company’s latest acquisition in the psychedelics space and why it could prove to be an absolute game-changer over the coming quarters.

Unique Industry Exposure 

DELIC recently announced the acquisition of Complex Biotech Discovery Ventures (CBDV), a licensed psilocybin and cannabis research laboratory focused on extraction, analytical testing and chemical process development. Founded by award-winning chemist Dr. Markus Roggen and UBC Professor Glenn Sammis, the high-profile lab plays an important role in the industry.

Click here to learn more about the CBDV team

CBDV has developed a profitable business focused on helping more than 50 blue chip psychedelics and cannabis clients with extraction optimization, analytical testing and chemical process development. After receiving a Section 56 exemption from Health Canada, enabling its lab to process Controlled Substances like psilocybin and cannabis, the company is extremely well-positioned to further advance psilocybin-related intellectual property development.

As one of just a handful of licensed psilocybin research labs in Canada, the company aims to build out an intellectual property (IP) portfolio of psilocybin analogs, novel compounds and delivery methods that could be used in future medical treatments including depression, anxiety, PTSD, and opioid and substance abuse. The company also intends to apply for a dealers’ license to commercialize its research and IP.

The acquisition provides DELIC with a profitable business and relationships across the psychedelics and cannabis industries along with the blue-sky potential for intellectual property development and licensing opportunities. The latter could eventually pave the way for high-margin recurring revenue as psychedelics could become mainstream therapies. 

Click here to receive an investor presentation and corporate updates

 Building on Expertise

DELIC’s management team, in particular CEO Matt Stang, has a background in relationships and branding, having built High Times into the cannabis industry’s preeminent media and events empire. The acquisition of CBDV opens the door to new relationships throughout the psychedelics industry while potentially adding new clients from existing relationships in cannabis.

In addition to these synergies, DELIC has already built a growing media presence in the psychedelics industry that it can leverage to build out CBDV’s business, including its Reality Sandwich brand and its Meet Delic wellness summit. The cross-pollination of these audiences between DELIC and CBDV could help expand near-term revenue and unlock future value.

The CBDV acquisition also adds strong scientific talent to DELIC’s overall management team. Dr. Roggen brings a wealth of knowledge and industry experience that’s hard to find given the industry’s nascent stage. This knowledge and experience could help transform other businesses that DELIC acquires and better inform its long-term strategy in the space.

Looking Ahead

DELIC’s acquisition of Complex Biotech Discovery Ventures represents a turning point in its plan to become a leader in the space. In addition to adding a profitable business to the mix, the acquisition provides access to key blue-chip relationships across the psychedelics and cannabis industries and unique synergies for its media properties and events.

Click here to receive an investor presentation and corporate updates

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading